Partner Fund Management »

Mirum Pharmaceuticals shares owned by Partner Fund Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.7M 32k 117.07

More positions owned by Partner Fund Management

Ascendis Pharma A/s Ord Shs (ASND)
Axsome Therapeutics (AXSM)
Eli Lilly & Co. (LLY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Humana (HUM)
UnitedHealth (UNH)
Neurocrine Biosciences (NBIX)
Inhibrx Biosciences (INBX)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Icon Pub SHS (ICLR)
Tenet Healthcare Corp Com New (THC)
Edwards Lifesciences (EW)
Waters Corporation (WAT)
Centene Corporation (CNC)

View all positions for Partner Fund Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
Jupiter Topco
BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
T. Rowe Price Associates
William Blair Investment Management
Geode Capital Management
Invesco
Wellington Management Company
Eventide Asset Management
Tang Capital Management

View all funds holding Mirum Pharmaceuticals